CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Detalles Bibliográficos
Autores principales: Bravaccini, Sara, Maltoni, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448267/
https://www.ncbi.nlm.nih.gov/pubmed/30944011
http://dx.doi.org/10.1186/s13058-019-1134-z
_version_ 1783408667215790080
author Bravaccini, Sara
Maltoni, Roberta
author_facet Bravaccini, Sara
Maltoni, Roberta
author_sort Bravaccini, Sara
collection PubMed
description
format Online
Article
Text
id pubmed-6448267
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64482672019-04-15 CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough? Bravaccini, Sara Maltoni, Roberta Breast Cancer Res Letter BioMed Central 2019-04-03 2019 /pmc/articles/PMC6448267/ /pubmed/30944011 http://dx.doi.org/10.1186/s13058-019-1134-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Bravaccini, Sara
Maltoni, Roberta
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
title CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
title_full CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
title_fullStr CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
title_full_unstemmed CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
title_short CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
title_sort cd68, cd163, and matrix metalloproteinase 9 (mmp-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448267/
https://www.ncbi.nlm.nih.gov/pubmed/30944011
http://dx.doi.org/10.1186/s13058-019-1134-z
work_keys_str_mv AT bravaccinisara cd68cd163andmatrixmetalloproteinase9mmp9inbreasttumormicroenvironmenttopredictbreastcancersurvivalaretheyenough
AT maltoniroberta cd68cd163andmatrixmetalloproteinase9mmp9inbreasttumormicroenvironmenttopredictbreastcancersurvivalaretheyenough

Ejemplares similares